Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes

BACKGROUND: 5-azacytidine (5-AZA) improves survival of patients with higher-risk myelodysplastic syndromes (MDSs) and oligoblastic acute myeloid leukemia (AML); however, predictive factors for response and outcome have not been consistently studied. METHODS: This study of the Hellenic MDS Study Grou...

Descripción completa

Detalles Bibliográficos
Autores principales: Papageorgiou, Sotirios G., Kotsianidis, Ioannis, Bouchla, Anthi, Symeonidis, Argyris, Galanopoulos, Athanasios, Viniou, Nora-Athina, Hatzimichael, Eleftheria, Vassilakopoulos, Theodoros P., Gogos, Dimitrios, Megalakaki, Aikaterini, Zikos, Panagiotis, Diamantopoulos, Panagiotis, Kourakli, Alexandra, Giannoulia, Panagiota, Papoutselis, Menelaos, Poulakidas, Elias, Arapaki, Maria, Vardi, Anna, Anagnostopoulos, Achilles, Mparmparousi, Despoina, Papaioannou, Maria, Bouronikou, Eleni, Dimou, Maria, Papadaki, Helen, Panayiotidis, Panayiotis, Pappa, Vasiliki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727043/
https://www.ncbi.nlm.nih.gov/pubmed/33343854
http://dx.doi.org/10.1177/2040620720966121

Ejemplares similares

Ejemplares similares